Ailanthone targets p23 to overcome MDV3100 resistance in castration-resistant prostate cancer.
He Y, Peng S, Wang J, Chen H, Cong X, Chen A, Hu M, Qin M, Wu H, Gao S, Wang L, Wang X, Yi Z, Liu M.
He Y, et al. Among authors: chen a, chen h.
Nat Commun. 2016 Dec 13;7:13122. doi: 10.1038/ncomms13122.
Nat Commun. 2016.
PMID: 27959342
Free PMC article.